Last reviewed · How we verify
MT-4129
At a glance
| Generic name | MT-4129 |
|---|---|
| Sponsor | Tanabe Pharma Corporation |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MT-4129 CI brief — competitive landscape report
- MT-4129 updates RSS · CI watch RSS
- Tanabe Pharma Corporation portfolio CI